CellProthera inches closer to Phase III trial for heart attack cell therapy

CellProthera inches closer to Phase III trial for heart attack cell therapy

Speaking at a press conference, CellProthera’s CEO said the company is moving into the final phase of clinical development for its product.

ClinicalTrials arena – Robert Barrie | August 30, 2024

Read on line